552
P. Singh et al.
13. Dey SK, Bag B, Dey DK, Gramlich V, Li Y, Mitra S. Synthesis
and characterization of copper(II) and zinc(II) complexes contain-
ing 1-phenyl-3-methyl-4-benzoyl-5-pyrazolone. Z Naturforsch.
2003;58b:1009–14.
14. De Souza RA, Mauro AE, Netto AVG, Da Cunha GA, De
Almeida ET. Synthesis, characterization, and thermal behavior of
palladium(II) coordination compounds containing isonicotina-
mide. J Therm Anal Calorim. 2011;106:375–8.
15. Zoroddu MA, Zanetti S, Pogni R, Basosi R. An electron spin
resonance study and antimicrobial activity of copper(II)-phe-
nanthroline complexes. J Inorg Biochem. 1996;63:291–300.
16. Ruiz M, Perello L, Server-Carrio J, Ortiz R, Garcia-Granda S,
Diaz MR, Canton E. Cinoxacin complexes with divalent metal
ions. Spectroscopic characterization. Crystal structure of a new
dinuclear Cd(II) complex having two chelate-bridging carboxyl-
ate groups. Antibacterial studies Canton. J Inorg Biochem. 1998;
69:231–9.
All the complexes show good activity against the test
organism with IC50 values in the range between 0.390 and
0.508 lM. Among all these compounds, 2a is more active.
Cytotoxicity profile, thermal and single crystal studies of
the compounds is in progress.
Acknowledgements The authors are thankful to Dr. Amir Azam,
Jamia Milia Islamia University, New Delhi, for screening biological
activity of the synthesized compounds. This study was supported by
UGC New Delhi [Grant No. F.4-3/2006(BSR)/11-84/2008 (BSR)].
References
1. Onoa GB, Moreno V, Font-Bardia M, Solans X, Perirez JM,
Alonso C. Structural and cytotoxic study of new Pt(II) and Pd(II)
complexes with the bi-heterocyclic ligand mepirizole. J Inorg
Biochem. 1999;75:205–12.
17. Ramadan M. Structural and biological aspects of copper(II)
complexes with 2-methyl-3-amino-(3H)-quinazolin-4-one. J Inorg
Biochem. 1997;65:183–9.
18. Carolina VB, Fillipe VR, Netto AVG, Shimura B, Frem RCG,
Mauro AE, Carlos IZ, Ananias SR, Quilles MB. New palla-
dium(II) complexes with pyrazole ligands part I. Synthesis,
spectral and thermal studies, and antitumor evaluation. J Therm
Anal Calorim. 2011;106:483–8.
19. World Health Organization WHO/PAHO/UNESCO report of a
consultation of experts on amoebisasis, weekly epidemiological
record of the WHO 1997;72:97.
20. Ghosh S, Chan JMW, Lea CR, Meints GA, lewis JC, Tovian ZS,
Flessner RM, Loftus TC, Bruchhaus I, Kendrick H, Croft SIL,
Kemp RG, Kobayashi S, Nezaki T, Oldfield E. Effects of bis-
phosphonates on the growth of Entamoeba histolytica and Plas-
modium species in vitro and in vivo. J Med Chem. 2004;47:
175–87.
21. Kandil SS, Abdel-Hay FI, Issa RM. Thermal studies of cobalt(II),
nickel(II) and copper(II) complexes of 4-(sulfonylazido pheny-
lazo) pyrazolones. J Therm Anal Calorim. 2001;63:173–80.
22. Da Silva PB, Terra PH, Frem RCG, Netto AVG, Mauro AE.
Synthesis, characterization, and investigation of the thermal
behavior of Cu(II) pyrazolyl complexes. J Therm Anal Calorim.
2011;106:495–9.
2. Abid M, Azam A. Synthesis and antiamoebic activities of 1-N-
substituted cyclised pyrazoline analogues of thiosemicarbazones.
Bioorg Med Chem. 2005;13:2213–20.
3. Bharti N, Shailendra Sharma S, Naqvi F, Azam A. New palla-
dium(II) complexes of 5-nitrothiophene-2-carboxaldehyde thio-
semicarbazones:synthesis, spectralstudiesandInvitroanti-amoebic
activity. Bioorg Med Chem. 2003;11:2923–9.
4. Navarro JAR, Lippert B. Simple 1:1 and 1:2 complexes of metal
ions with heterocycles as building blocks for discrete molecular
as well as polymeric assemblies. Coord Chem Rev. 2001;222:
219–50.
5. Peisach J, Aisen P, Blumberg W, editors. The biochemistry of
copper. New York: Academic Press; 1966.
6. Cowley AR, Dilworth JR, Donnelly PS, Gee AD, Heslop JM.
Acetylacetonate bis(thiosemicarbazone) complexes of copper and
nickel: towards new copper radiopharmaceuticals. Dalton Trans.
2004;16:2404–12.
7. Athappan P, Shanthi P, Murugesan R, Natarajan C. Synthesis and
Spectral Studies of Cobalt (II), Nickel (II), copper(II) and zinc(II)
complexes of 3-(2-hydroxy-1-naphthyl)-5-(4-X-phenyd-2-pyraz-
olines. Synth React Inorg Met. 1993;23:1445–67.
23. Seebacher W, Michl G, Belaj F, Brun R, Saf R, Weis R. One-pot
syntheses of 2-pyrazoline derivatives. Tetrahedron. 2003;59:
2811–9.
24. Budakoti A, Abid M, Azam A. Synthesese, characterization and
in vitro antiamoebic activity of new Pd(II) complexes with 1-N-
substituted thiocarbamoyl-3, 5-diphenyl-2-pyrazoline derivatives.
Eur J Med Chem. 2007;42:544–51.
25. Bhat AR, Athar F, Azam A. Bis-pyrazolines: synthesis charac-
terization and antiamoebic activity as inhibitors of growth of
Entamoebica histolytica. Eur J Med Chem. 2009;44:426–31.
26. Wright CW, O’Neill MJ, Phillipson JD, Warhurst DC. Use of
microdilution to assess in vitro antiamoebic activities of Brucea
javanica fruits, Simarouba amara stem, and a number of quas-
sinoids. Antimicrob Agents Chemother. 1988;32:1725–9.
8. Chandra S, Jain D, Sharma AK, Sharma P. Coordination modes
of a Schiff base pentadentate derivative of 4-aminoantipyrine
with cobalt(II), nickel(II) and copper(II) metal ions: synthesis,
spectroscopic and antimicrobial studies. Molecules. 2009;14:
174–90.
9. Kuncheria J, Aravindakshan KK. Synthesis, characterization and
antitumour studies of metal chelates of N1-isonicotinoyl-3-methyl-
4-(p-hydroxybenzilidene)-2-pyrazolin-5-one. J Chem Technol
Biotechnol. 1993;57:43–7.
10. Sorenson JR. Copper complexes offer a physiological approach to
treatment of chronic diseases. J Prog Med Chem. 1989;26:
437–68.
11. Sharma KV, Sharma V, Dubey RK, Tripathi UN. Antimicrobial
and anti-inflammatory studies of 5(20-hydroxyphenyl)-3-(4-x-
phenyl)pyrazolinates of copper(II) and their addition complexes
with donor ligands. J Coord Chem. 2009;62:493–4.
12. Zhang S, Zhu Y, Tu C, Wei H, Yang Z, Lin L, Ding J, Zhang J,
Guo Z. A novel cytotoxic ternary copper(II) complex of 1,10-
phenanthroline and L-threonine with DNA nuclease activity.
J Inorg Biochem. 2004;98:2099–100.
123